The 32nd National Congress on Digestive Diseases (FISMAD), one of the most important scientific events in Italy dedicated to gastroenterology and digestive endoscopy, concluded just a few days ago in Rome at the Ergife Palace Hotel.

Once again, Euromedical played a leading role, confirming its position as a technological and scientific partner alongside healthcare professionals.

A key meeting point for the clinical community

The congress represented a valuable opportunity for dialogue among specialists, opinion leaders, and industry players, with a strong focus on the latest developments in diagnostic and therapeutic approaches.

In this context, Euromedical showcased its extensive expertise in endoscopy, presenting innovative solutions and advanced technologies designed to enhance clinical outcomes, operational efficiency, and patient experience.

Technological innovation and clinical value

At the exhibition area, the Euromedical team welcomed numerous healthcare professionals, fostering direct and meaningful discussions about real clinical needs.

Particular interest was shown in technologies dedicated to endoscopy and minimally invasive procedures, which are increasingly central to the evolution of modern medicine.

Euromedical’s approach goes beyond the distribution of medical devices, focusing on the development of integrated solutions, supported by training, technical consultancy, and continuous scientific education.

Supporting innovation, every day

Participation in FISMAD 2026 further reinforces Euromedical’s commitment to advancing medical and scientific innovation, actively contributing to the dissemination of cutting-edge technologies and the professional growth of healthcare providers.

Being present in high-level scientific environments means, for Euromedical, listening, engaging, and building the future of healthcare together, with a clear objective: improving the quality of care and supporting healthcare professionals in their daily work.